Method for treating essential arterial hypertension

FIELD: medicine, cardiology, physiotherapy.

SUBSTANCE: it is necessary to carry out a multiple-seance transcutaneous impact with low-intensity infrared laser radiation with the help of laser therapeutic equipment paravertebrally at frequency being 100 Hz. Paravertebral areas should be irradiated at C3-C7 level. An emitter should be constantly replaced transcutaneously so, that the duration of irradiation of 1 point should not exceed 2 sec. The duration of irradiation seance should be established individually by taking into account the area of irradiation so, that exposure dosage should correspond to 0.2 mJ/sq. cm/area. The innovation removes side effects such as the appearance of "acute waves" at EEG, standardizes the dosages of laser radiation, decreases the duration of temporary inability to work and increases the quality of rehabilitation in such patients.

EFFECT: higher efficiency of therapy.

1 ex


The invention relates to medicine, namely to cardiology and physical therapy to treatment esenciales arterial hypertension (hypertension) laser radiation.

A prototype of the invention taken treatment of hypertension by repeated session transcutaneous effects of low-intensity infra-red (λ=0.89 microns) laser using a semiconductor laser installation "Pattern" on the relative cardiac dullness within 5-10 minutes [Tsholetsegile, Avebury, Masapan "application of the semiconductor laser Pattern for the treatment of hypertension in the outpatient setting". /"Physical medicine". - 1992. - Vol.2. - №3-4. - P.46-48].

As noted by the authors, to the end of the course of laser therapy in patients systolic blood pressure dropped from 159,9±4.5 to 150,4±4.0 mm Hg; diastolic blood pressure decreased from 96,7±2,0 up to 91.6±1.9 mm Hg, which was not statistically significant [Tsholetsegile, Avebury, Masapan "application of the semiconductor laser Pattern for the treatment of hypertension in the outpatient setting". /"Physical medicine". - 1992. - Vol.2. - №3-4. P.47]. In addition, the target blood pressure in patients with hypertension, according to clinical studies, less than 140/90 mm Hg [guidelines for the diagnosis and l is the treatment of hypertension. /"Arterial hypertension". - V.10. No. 2. - P.65-92]. Thus, the disadvantage of this method is unreliable and insufficient reduction of blood pressure, because by the end of the treatment target blood pressure was not reached. Furthermore, the method of the prototype is not regulated by the frequency of the pulses, thus, does not provide for the calculation of the dose of laser radiation received by the patient during the session and for the course.

There is also known a method of treating vascular disorders in pathological menopause in women by repeated session transcutaneous effects of low-intensity infra-red (λ=0.89 microns) laser radiation with a laser installation Pattern (with a pulse power of 2-3 watts) on peripheral sympathetic education (left and right superior cervical and stellate nodes of the sympathetic trunk and vertebral nerves) in a certain sequence, with a frequency of 300-1500 Hz within 1-5 minutes. During one session irradiate two points, and in the first session - the projection of the upper cervical sympathetic ganglion (left and right), the second projection of the starry host (left and right), the third projection of the spinal nerve (left and right), then the cycle is repeated 4 more times, frequency, and duration of exposure determine individually the level of blood pressure of the patient. The irradiated point subsequently is conducted on the leading edge of the Sterno sternocleidomastoid muscle (at the level of the mandibular angle and Sterno-clavicle joint) and on line, connecting the upper edge of the mastoid process and the spinous process of C2, at the junction of its outer and middle thirds [Liikennemelua, a Method of treating vascular disorders in the climacteric syndrome in women. Patent No. 2022553 from 15.11. 94]. As follows from the example of the practical implementation of the method and outcomes specified by the author, the method can reduce blood pressure in persons with blood pressure 150/90 mm Hg or higher, for example, from 160/100 mm Hg to 140/90 mm Hg, i.e. more efficient than the method prototype. However, the target blood pressure of less than 140/90 mm Hg in the treatment by this method is also not achieved, i.e. it is not efficient enough to ensure esenciales arterial hypertension.

It was established that laser exposure exceeding the exposure dose of 0.3 MJ/cm2when the irradiation of the brain stem can lead to the development of adverse physiological effects in the form of increased epileptiform activity and pathological medlennovolnovoj rhythm that is a complication of laser therapy and limits the application of this method in patients with convulsive seizures in history and Ostrovnoy activity in the EEG [Auspolen. "Optimization of modes of infrared laser therapy in patients with autonomic-the vascular dystonia on the basis of neurophysiological criteria: abstract of thesis... candlenut. - Obninsk, 2003. - P.17-18].

Therefore, the disadvantage of the method proposed Lioresalo is the presence of a risk of side effects in the appearance of epileptiform activity, as the method does not exclude the penetration of the laser radiation on the brain stem at the irradiation point of the projection of the spinal nerve and involves the use of exposure dose 4,67-175,32 MJ/cm2. Its application leads to an overestimation of the energy of the irradiation parameters, both single and total (per session, per course). The way the prototype also does not differentiate between the treatment considering the area of exposure and exposure rate, which reduces the effectiveness of the treatment esenciales arterial hypertension. Furthermore, the method is not standardized by the exposure dose.

The technical result is to increase the effectiveness of treatment esenciales hypertension laser radiation by taking into account individual medical and biological parameters of the patient, a more precise definition of the length of exposure for each patient.

The technical result is achieved by including multiple transcutaneous effects of pulsed low-intensity infrared laser radiation with a laser therapeutic installation method for the treatment of es the social arterial hypertension involves the irradiation of the paravertebral regions at the level of C3-C7 (right and left) with a frequency of 100 Hz, in the course of which the emitter constantly move without interruption from the skin, in the downward direction, so that the exposure time of each point within the zone does not exceed 2 seconds, the duration of the session is determined individually, taking into account the area of irradiation, so that the exposure dose was 0.2 MJ/cm2one area. The duration of exposure (t) calculated by the formula:

where t is the exposure time, s;

0,1×10-3- exposure dose, j/cm2;

S - area irradiation, cm2;

P - average pulsed radiation power, W;

100 - pulse repetition rate, Hz;

τ - pulse duration, S.

As can be seen from the formula for calculation of the exposure time is taken into account, the average pulse power of the beam and the pulse duration, which are specified in the technical passport of the laser apparatus. Thus, the treatment may be carried out using laser devices with different power and pulse duration that provides the versatility of the proposed method.

As shown by experiments on animals [CAD, Mailan, Egharevba, Wahooo "Effects of low intensity infrared laser radiation on models of biological systems. Ivanovo: Yugma, 2002. P.87-101], "sharp is any" on EEG seizures, focal changes in brain tissue appear when the exposure dose of 0.3 MJ/cm2and more (region).

Therefore, the proposed method comprising determining the time of exposure by the exposure dose of 0.2 MJ/cm2(i.e. less than 0.3 MJ/cm2) eliminates the risk of the emergence of epileptiform activity on the background of treatment.

Fixed exposure dose allows to take into account the area of exposure - specific individual medical-biological indicator and calculate the session and the exposure time of each zone for a specific patient, i.e. to individualize treatment esenciales arterial hypertension. Check exposure dose allows to take into account the radial load on the body of patients.

Introduction paravertebral zone exposure from C3 to C7 allows to irradiate the peripheral sympathetic ganglia, and vertebral arteries, i.e. provides a comprehensive effect on the autonomic nervous system and the rheological properties of blood, which increases the effectiveness of treatment esenciales arterial hypertension.

The introduction of continuous movement of the feed into the exposure zone so that the exposure time of one point does not exceed 2 seconds, provides for prevention of overdose of laser radiation, da is of the vessels and nerve trunks laser radiation, prevention of focal fibrosis in the sympathetic ganglia after treatment, increases the effectiveness of the treatment laser radiation esenciales arterial hypertension.

It is known that the pulse frequency of 100 Hz is the resonance of the nervous system, since it coincides with the frequency of pulsation of neurons, and high dose laser irradiation with a frequency of 100 Hz have on the nervous tissue is minimal, compared with other frequencies, the damaging effect. Therefore, the introduction of the exposure right and left paravertebral areas with a frequency of 100 Hz at the level of C3-C7 prevent leakage of the laser radiation to the brain, provides for the development of reflex component of the response to treatment contributes to the correction of vegetative regulation of vascular tone, which increases the effectiveness of treatment esenciales arterial hypertension.

An example of the practical implementation of the method.

1. Patient K., 49 years. Diagnosis: Esentially arterial hypertension (Hypertension), 2 tbsp. HI. The patient was bothered by headaches, dizziness accompanied by nausea, low performance, feeling palpitations, aching pain in the heart, not associated with physical activity and activity-dependent nitroglycerin, sleep disturbance. Antihypertensive therapy consisted of Enap 20 mg 2 times a day, indepa the ID 2.5 mg in the morning. Blood pressure medication 160/100 mm Hg According to the spectral analysis of HRV before treatment were reduced: total spectral power (1497,15 MS2/Hz) and each of its three components (oscillations of high 541,07 MS2/Hz, low 340,08 MS2/Hz and very low frequencies 614,82 MS2/Hz). In the structure of the spectrum was dominated by oscillations of very low frequency, they accounted for 42%. Thus, the patient due to impaired adaptive capabilities of the organism occurred relative hyporeactivity the sympathetic nervous system in combination with the relative vagotonic, and prevailed humoral-metabolic regulation of the reactivity of the organism.

In accordance with the proposed method, the patient is assigned a daily session transcutaneous influence of low-intensity infrared laser radiation with a laser therapeutic settings "Mustang 026" paravertebral region C3-C7 area of 7 cm2with a pulse frequency of 100 Hz, with a constant emitter movement within the area without separation from the skin, so that the exposure time of each point does not exceed 2 seconds. The course of treatment - 10 sessions.

The duration of exposure (t) calculated by the formula:

where t is the time region is ing, C;

0,1×10-3- exposure dose, j/cm2;

S=7 cm2the area of irradiation;

P=8 W, the average peak power of the radiation;

100 - pulse repetition rate, Hz;

τ - pulse duration, S.

After putting in the formula of the individual square of the exposure and the characteristics of the laser system, we obtain that t=40 sec. Therefore, the total duration of the session 80 seconds (instead of 1-5 minutes, as in the method of the prototype).

After completion of the treatment: the woman disappeared headaches, dizziness, aching pain in the heart, palpitations, normalized sleep, improved mood, increased efficiency. On EEG "sharp waves" are not fixed. The total power spectrum after treatment increased to 1978,97 MS2/Hz (i.e. normalized); the contribution of very low-frequency component is reduced to 20%, which corresponds to the normalization of the reactivity of the organism, which objectively confirms the regression of clinical symptoms. Blood pressure decreased to 135/80 mm Hg (i.e. reaches the target level of blood pressure).

According to the prototype, in patients after treatment, in addition to lowering blood pressure systolic - to 150,4±4.0 mm Hg and diastolic - up to 91.6±1.9 mm Hg, decreased the number of patients complaining of headache pain is, dizziness, noise in the head, pain in the heart; not changed the frequency of complaints of patients on sleep disturbance, palpitations, interruptions in heart work, poor health. Dynamics of rheoencephalography in patients with regression of cerebral symptoms were characterized by unreliable changes in arterial inflow, the velocity of blood flow in large, medium and small cerebral arteries, venous outflow from the cranial cavity. Significantly improved with 22,94±1.06 to 20,10±1,01 (norm 15,04±2,02) the ratio of the velocity of blood arteries and duration of the cardiac cycle, indirectly characterizing the state of autonomic regulation of heart rhythm. [Tsholetsegile, Avebury, Masapan "application of the semiconductor laser Pattern for the treatment of hypertension in the outpatient setting". /"Physical medicine". - 1992. - Vol.2. - №3-4. - P.48].

Therefore, the proposed method has higher clinical effect, providing a stronger hypotensive effect and normalizes the function of the autonomic nervous system.

In the group of patients (95 people)treated with laser therapy on the proposed method, blood pressure decreased up to 132.6±4,2/83±2.6 mm Hg In 72,16% of cases, in addition to achieve the target pressure, the improvement of health, the disappearance of the complaints noted normal is within cerebral blood flow (according to rheoencephalography reduced the severity of vascular vasomotor reactions, normal vascular tone, increases blood flow velocity in medium and small cerebral arteries, improves the tone of the veins and venous outflow), the reduction or disappearance of irritation hypothalamic structures" (electroencephalogram), improve the functioning of the autonomic nervous system (the increase of the power spectrum was 32% compared to the initial value, the structure of the spectrum is normalized). "Sharp waves in the EEG after treatment by the proposed method is not registered.

Thus, the proposed method, including transcutaneous exposure to laser radiation with a frequency of 100 Hz on the paravertebral region to the right and to the left at the level of C3-C7, in which the emitter constantly move without interruption from the skin, so that the exposure time of one point does not exceed 2 seconds, the duration of the session is determined individually, taking into account the area of irradiation, so that the exposure dose was 0.2 MJ/cm2for each region, increases the effectiveness of therapy esenciales hypertension due to the normalization of vascular tone, contributing to the correction of cerebral blood flow, reduction of vegetative dysfunction, and absence of side-effects in the form of appearance after treatment "sharp waves on EEG.

The advantage is the EU ETS invention in relation to the prototype is to standardize the dose of laser radiation (session and course), the possibility of use for treatment laser devices with different technical characteristics.

The use of the invention is to reduce the duration of temporary disability, improve the quality of rehabilitation.

The method of treatment esenciales hypertension, including multiple session transcutaneous effects of pulsed low-intensity infrared laser radiation with a laser therapeutic units, characterized in that the irradiated paravertebral region at the level of C3-C7 (right and left) with a frequency of 100 Hz, and the emitter constantly move without interruption from the skin so that the exposure time of one point does not exceed 2, the duration of the session is determined individually, taking into account the area of exposure so that the exposure dose was 0.2 MJ/cm2one area.


Same patents:

FIELD: medicine, laser surgery.

SUBSTANCE: the present innovation deals with treating neuroorthopedic vertebral diseases: it is necessary to apply a puncture needle into an affected disk, introduce a needle of laser light guide, form the canals in the disk under laser action and fulfill direct retrograde vaporization of disk's hernia under the control of visualization means. Moreover, hernial vaporization should be carried out under roentgenocontrast control - discography, or myelography, or disko-myelography at introducing a contrast substance into the disk or a dural sac, or into the disk and the dural sac, correspondingly. Application of the present method enables to obtain specifying significant information in the course of operation on localization of hernial formations at different degree of disk's lesion at decreasing radiation loading upon a patient and, also, enables to simplify the process of operation and shorten the time for fulfilling it without any detriment to its quality.

EFFECT: higher efficiency.

3 ex

FIELD: medicine.

SUBSTANCE: method involves intravenously administering Photoditasin at a dose of 1 mg/kg 2-3 hours before operation. Catheter is introduced into urinary bladder with spherical and cylindrical balloons, the first one being filled with a liquid and pulled toward urinary bladder cervix, the second one, having fiber optic fibers with fiber optic fiber placed in it and provided with cylindrical diffuser, is also filled with liquid and placed in prostatic region of urethra and irradiated with diode laser having specific capacity of 200 mW/cm2 with specific light energy doze being equal to 150-300 J/cm2 during 12,5-25 min.

EFFECT: enabled hyperplastic tissue photodestruction eliminating infravesical obstruction; improved urodynamic properties; improved patient life quality.

FIELD: medicine.

SUBSTANCE: method involves irradiating tumor in trans-scleral and transpupillary mode with laser radiation using photodynamic therapy approach with Photosense photosensibilizer being applied. Irradiation is administered 48-72 h later, after having introduced the photosensibilizer with radiation source having wavelength of 675 nm and luminous radiation dose of 80-800 mW/cm2. Photodynamic therapy is applicable first in transcleral mode and then in transpupillary mode. It is also applicable first in transpupillary mode and then in trans-scleral mode.

EFFECT: enhanced effectiveness in optyimizing treatment.

3 cl

FIELD: medicine.

SUBSTANCE: method involves applying infrared transpupillary laser radiation therapy directly to injured blood vessels. Treatment parameters are wavelength of 810 nm, radiation power of 300-400 mW, spot diameter of 0.8-1.2 mm, exposure time equal to 1 min. 1-2 treatment sessions are given with 1-2 months long pause.

EFFECT: enhanced effectiveness of subthreshold photocoagulation; recovered venous blood circulation; avoided coagulate production.

FIELD: medicine, traumatology, orthopedics.

SUBSTANCE: it is necessary to irradiate affected area with low-intensity He-Ne laser at wave length of 0.63 mcm and density of radiation power being 10 mW/sq. cm, impact exposure - 10 min. Quantity of seances corresponds to 10. Before irradiation one should apply a single-layer filter cloth impregnated with 1%-carypazim solution onto the skin of affected area. The innovation enables to quickly remove pain syndrome, reconstruct the volume of movements in affected area and achieve prolonged remission of the disease mentioned.

EFFECT: higher efficiency of therapy.

2 dwg, 2 ex, 1 tbl

FIELD: medicine, urology.

SUBSTANCE: it is necessary to prescribe the intake of medicinal preparations; additionally, one should affect perineum, bladder's area and that of uterine adnexa with high-frequency electromagnetic field which has been developed with sinusoidal signal at carrier frequency ranged 200-1000 kHz, amplitude-modulated low-frequency signal at constantly altering frequency ranged 50-1000 Hz with the help of inductive emitter. Moreover, field intensity at emitter's surface should be within 1.0-1.5 v/m. Simultaneously, one should irradiate with low-intensity quasimonochromatic pulsing radiation at red-radiation wave length being 640 nm, infrared radiation wave length being 840 nm and 940 nm. Total density of radiation corresponds to 2 mW/sq. cm, area of impact is 10 sq. cm, frequency of pulsation is 100 Hz, the procedure should be carried out once daily for 10 min onto perineal area, 10 min for bladder's area and per 5 min for uterine adnexa area from each side. The cycle consists of about 8-10 procedures.

EFFECT: increased curative result.

2 ex

FIELD: medicine, neurosurgery.

SUBSTANCE: one should affect affected nerve intrasurgically with light diode blue-spectrum radiation at radiation power being 0.5 mW, wave length being about 0.46-0.52 mcm, at the mode of constant impact, for 5 min/1 field, from the distance of 1-2 cm. The innovation improves metabolism, decreases venous congestion and edema at the level of nervous lesion.

EFFECT: higher efficiency of therapy.

4 dwg, 2 ex

FIELD: medicine, oncology, ophthalmooncology.

SUBSTANCE: the present innovation deals with treating malignant neoplasms of skin and mucosa and, also, intraocular neoplasms. It is necessary to introduce a preparation followed by laser irradiation of a neoplasm. As a preparation one should perform the intake of porphyrin derivative of plant origin perorally to an empty stomach at the dosage of 10.0 mg/kg, and in 3-4 h it is important to carry out laser irradiation of the neoplasm at wave length being correspondent to absorption of light radiation with porphyrin derivative, at the dosage of 300-900 J/sq. cm. The innovation enables to achieve complete or partial tumoral regression, exclude invasive technique for preparation introduction, the onset of allergic reactions and the risk for being infected with viral diseases, increase survival rate and life duration in patients.

EFFECT: higher efficiency of therapy.

1 cl, 3 ex, 1 tbl

FIELD: phototreatment of alive biotissue.

SUBSTANCE: it is necessary to fulfill phototreatment of biotissue that contains certain part with chromophore performed due to light-induced cell apoptosis of this part of biotissue that leads to its atraumatic modification, to removal, as well. The innovation deals with irradiating biotissue with light radiation at wave length ranged 500-2500 nm at density of energy being insufficient for destruction, but sufficient for inducing cell apoptosis of chromophore-containing biotissue. The innovation enables to perform phototreatment for inhibiting the growth of unfavorable hair, removing vascular defects and cutaneous pigment spots, remodeling the skin, reducing sebaceous glands in case of acne, removing neoplasms, reducing and removing hypertrophic and keloid cicatrices at induction of light-induced cell apoptosis of these parts of biotissue. Moreover, the innovation enables to carry out modification, the removal of biotissue atraumatically, without any cosmetically unacceptable complications, as well.

EFFECT: higher efficiency of phototreatment.

22 cl, 3 dwg, 7 ex, 3 tbl

FIELD: medical engineering.

SUBSTANCE: device has laser mounted on its optical axis and fixed diffusely scattering screen. An additional non-transparent screen has slits and zones transparent for radiation to pass. The additional screen is placed behind the diffusely scattering screen. One or several reflectors having curved reflecting surface are placed between the laser and diffusely scattering screen. The reflectors are movable relative to laser radiation beam to enable laser radiation beam to be directed to the reflecting surface of at least one reflector at any time moment.

EFFECT: enhanced effectiveness of diagnosis and treatment procedures.

3 dwg

FIELD: medicine, oncology.

SUBSTANCE: during the first day of therapy it is necessary to affect the lesion focus with alternating magnetic field at induction being 5-160 mTl, frequency of 50-100 Hz for about 7-10 min. Out of peripheral vein one should sample blood into two vials with hemoconservant per 100 ml/each; one vial should be supplemented with doxorubicin at the dosage of 50 mg/sq. m, the second vial - with 5-fluorouracil 750 mg/sq. m. Both vials should be incubated. Then it is necessary to inject intravenously by drops the content of the first, and then of the second vial for a patient. During the period since the first day up to the seventh one it is necessary to introduce cyclophosphan intramuscularly per 200 mg/sq. m. Since the first up to the tenth day of therapy one should affect with alternating and direct magnetic field. On the eighth day after seances of magnetic therapy one should repeatedly introduce anti-tumor chemopreparations at the same dosages and sequence. In two weeks it is necessary to repeat the above-mentioned curative impacts. In two weeks after the last introduction of chemopreparations one should fulfill surgical removal of lesion focus. The innovation enables to avoid side toxic manifestations of chemopreparations and notching of sutures and, also, healing due to secondary tension.

EFFECT: higher efficiency of therapy.

1 ex

FIELD: medicine, surgery.

SUBSTANCE: the present innovation deals with preventing purulent-septic complications in early post-surgical period at surgical treatment of gangrene-complicated ischemic foot form. During 3-5 d before operation and during 7-8 d after it one should introduce perorally ADP-37 preparations for patients at the dosage of 6 capsules daily followed by intramuscular injection of mexidol immediately after operation at the dosage of 2.1 mg/kg body weight, and during the next 3 d - at the same dosage every 12 h. Surgical wound should be treated with a gel that contains 2%-mexidol followed by affecting the wound with impulse magnetic field at 0.5-1.0 Tl intensity.

EFFECT: the innovation enables to prevent the development of purulent complications, stimulate reparative process, reconstruct the structure and the functioning of microcirculatory system in limb's soft tissues.

2 ex

FIELD: medicine; medical engineering.

SUBSTANCE: method involves applying high-frequency electromagnetic field generated by M sine wave signals with bearing frequencies chosen in 100-1000 kHz frequency bandwidth and amplitude-modulated low frequency signal with permanently varying frequency and amplitude in bandwidth of 10-10000 Hz by means of M active elements manufactured as inductance coil having split winding connected to active oscillator scheme. A treatment is carried out once a day within 20-30 min. The number of procedures is equal to 10-15, intensity of a field at a surface of an element of influence is 0.2-2.0 V/m. The system for producing electromagnetic field has M treatment devices fixed on couch with their bases, manufactured from hard dielectric. Each device has modulator input of which is connected to power amplifier which input is connected to magnetic tape player output. The inductance coil of each active element has sectional winding.

EFFECT: enhanced effectiveness of treatment; reduced power consumption.

2 cl, 3 dwg

FIELD: medicine, ophthalmology.

SUBSTANCE: it is necessary to simultaneously affect an optic nerve and optic tract with impulse alternating electromagnetic field at 50 Hz frequency and induction amplitude ranged 3-15 mTl at time of impact being 10 min for 10 seances carried out daily at one and the same period of time. The innovation enables to intensify the flow of stimulation from retina into subcortical and cortical optic centers.

EFFECT: higher efficiency of therapy.

2 dwg, 2 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: method involves impregnating sterile gauze napkins with Tactivin solution, in the amount of 100 mcg per each napkin, and imposing it on mammary gland. Then, variable magnetic field treatment is applied. When applying the procedure one day and one hour prior to operation the napkins are arranged on both sides with respect to nodular formation, 3 cm far from it. When carrying out the procedure at the third day after operation, napkins are placed directly onto zone under operation.

EFFECT: reduced risk of complications in postoperative period.

FIELD: medicine.

SUBSTANCE: method involves applying sludge mud magnetophoresis beginning from the second adaptation day. The mud is enriched with mineral hydrogen sulfide water with hydrogen sulfide concentration of 350 mg/l every other day. Treatment session is 20 min long with reflexosegmental zones of vegetative heart innervation pretreated with 30% dimexide solution being acted. The zones are restricted with vertical lines passing along internal boundary of the left scapula and along vertebral column spinous processes line and restricted with horizontal lines, one passing at the level of VI cervical vertebra being upper boundary and at the IV thoracic vertebra level as lower boundary. Inductors are transversely arranged in rotating magnetic field. Treatment intensity is equal to 30 mTesla units. Impulse succession frequency is 25 Hz. General hydrogen sulfide water baths are prescribed beginning from the fifth day. The general hydrogen sulfide water baths with hydrogen sulfide concentration of 50-150 mg/l are given in exertional angina pectoris cases of the first functional class, the concentration being 50-100 mg/l in the second functional class exertional angina pectoris cases. Water temperature is 36°C and a procedure is 6-15 min long. The total treatment course is 10 physio- and 8 balneoprocedures long.

EFFECT: increased adaptive capabilities of organism; normalized lipid metabolism and lipid peroxidation indices; enhanced effectiveness of treatment; reduced risk of ischemic disease complications.

12 tbl

FIELD: medicine.

SUBSTANCE: human body is subject to influence of high-frequency variable magnetic field with frequency spectrum within 0,1-60 Hz, which range is divided to sub-ranges any of which coincides with frequencies of corresponding biological rhythm of human brain, namely, delta, theta, alpha, beta. Amplitudes of signals of sub-range change according to specific law with magnetic field total induction of 2-10 T of inside frequency sub-ranges influencing human body within time range of 3-12 minutes. Preliminary initial characteristics of patient's condition are revealed and registered in form of integral characteristic, which includes level of adaptation of human organism, vegetative regulation characteristic, central regulation characteristic, and psycho-emotional condition characteristic; after that patient is subject to influence of magnetic field. During making procedure, growth in integral factor of functional condition of patient is observed, and at time moment when level of the factor stays constant, the procedure is stopped. All the wave properties of brain are used for synchronization of operation of human organism and possibility of brake in response of central nervous system is eliminated.

EFFECT: improved efficiency.

2 cl, 4 dwg

FIELD: medicine, urology.

SUBSTANCE: one should affect ureteral area through ureteral projections with flicker-sound magnetic field, its spectral constituents being in the range of the following frequencies 2.5·10-4 - 2.5·101 Hz, and maximal amplitude of magnetic induction - within 0.1-0.5 mcTl. Duration of the procedure corresponds to about 30-60 min. The quantity of procedures - 1-3 daily. At detecting renal stones the diameter being above internal ureteral one should fulfill lithotrypsy before the impact with magnetic field. About 1-2 h before the impact with magnetic field it is necessary to introduce spasmolytic medicinal preparation. In the course of about 30-60 min before the impact with magnetic field and during this impact it is necessary to heat patient's body surface in area of ureteral projection. The innovation enables to shorten the duration of therapy.

EFFECT: higher efficiency.

3 cl, 3 ex

FIELD: medicine; physiotherapy; urology.

SUBSTANCE: method can be used for complex treatment of patients suffering from erectile prostatitis complicated with symptoms of erectile dysfunction. Perineum is subject to SMC-therapy proserin electrophoresis simultaneously with pulse magnetic field. Combined effect is performed within 2 steps. At first step, SMC-therapy proserin electrophoresis at perineum is performed at rectified mode of SMC-I (constant modulation) sort of operation at modulation frequency of 20-30 Hz, depth of modulation of 75-100%, current strength of 20-30 mA and duration of influence of 5-7 minutes. Simultaneously perineum area is subject to rectangular pulse magnetic field during 5-7 minutes. Frequency of rectangular pulse magnetic field equals to 20-30 Hz, magnetic induction is equal to 20-30 tesla. At second step the effect of proserin electrophoresis is performed at rectified mode IV (permanent frequency) of operation with modulation frequency of 20-30 Hz., depth of modulation of 100% and higher, duration of sendings 4s:6s and bipolar rectangular pulse magnetic field is used for influence during 8-10 minutes. Frequency of bipolar rectangular pulse magnetic field equals to 20-30 Hz. Longer period of remission is observed due to usage of combined influence of proserin electrophoresis and magnetic field at mentioned modes of operation.

EFFECT: improved electrophoresis permeability of cutaneous coverings; increased efficient concentration of proserin in prostate.

4 ex

FIELD: medicine; neurology; physiotherapy.

SUBSTANCE: areas of exit of brachial plexus and then areas of proximal and distal points of peripheral and central appendices of peripheral nerve subject to low-intensity laser radiation 10-12 days after surgery in 40-50 minutes after therapeutic physical training in contact and to provide stability. The last area of influence is area onto which the surgical operation was made. Wavelength of influence is 0,89 mcm, impulse power is 3 to 5 W, pulse frequency 80 Hz, time of influence onto one field is 1 to 2 minutes. During one procedure no more than 6 fields can be used. Course consists of 10-12 procedures taken daily. During second step, 10-12 daily procedures are taken, which procedures are performed by means of pulse magnetic field brought into contact with skin covers along projections of nerve trunk and muscles innerved by the trunks at frequency of 30pulse/minute, inductance of 0,5 to 1,0 T during 10-12 minutes.

EFFECT: accelerated recovery processes; reduced chance of post-operational complications.

1 ex, 4 tbl

FIELD: medical engineering.

SUBSTANCE: device has power supply source, electromagnetic oscillation source, treatment element, having two inductance coils connected in series and compliance, and capacitor forming an LC-circuit with the treatment element. The electromagnetic oscillation source is designed as self-excited oscillator, which oscillatory circuit is the LC-circuit with the treatment element. The device also has modulator unit set between the power supply source and self-excited oscillator circuit, control circuit connected to the self-excited oscillator circuit and having amplitude detector, AC amplifier and indicator unit connected in series and sectional U-shaped dielectric carcass having inductance coils of the treatment element mounted on its vertical elements and electric units of the device mounted on horizontal electric elements of the device. The self-excited oscillator produces high frequency oscillations in frequency bandwidth of 100-1000 kHz. The modulator unit has low frequency oscillator operating in the bandwidth of 10-5000 Hz. Carcass members are manufactured from hard dielectric material and connected to each other by means of flexible connection members.

EFFECT: wide range of functional applications.

2 cl, 2 dwg